General Dynamics Vs. Lockheed Martin: Buy General Dynamics for Deep Marine Backlogs

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • GD topped Q1 estimates on 21% Marine Systems growth; LMT missed EPS consensus and burned $291M in free cash flow.

  • GD's 192% cash conversion, four straight EPS beats, and $188B submarine-heavy backlog offer stronger downside protection than LMT's fixed-price program exposure.

  • LMT's $194B backlog and new Patriot and THAAD framework deals could still reward patient investors if recurring F-16 program charges stabilize.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Lockheed Martin didn't make the cut. Grab the names FREE today.

General Dynamics Vs. Lockheed Martin: Buy General Dynamics for Deep Marine Backlogs

© The U.S. and Peruvian navies t... (CC BY 2.0) by Official U.S. Navy Page

General Dynamics (NYSE:GD | GD Price Prediction) and Lockheed Martin (NYSE:LMT) reported Q1 2026 results pulling the two defense giants in opposite directions. General Dynamics beat on submarines and Gulfstream jets. Lockheed leaned on a record backlog to explain a messy quarter marked by fresh program charges and a cash flow reversal.

Submarines Carry GD. Program Charges Weigh On Lockheed.

General Dynamics posted EPS of $4.10 on revenue of $13.48 billion, with Marine Systems growing 21.0% and operating earnings there up 26.4%. Gulfstream delivered 38 aircraft versus 36 a year earlier, and Aerospace orders jumped 63%. CEO Phebe Novakovic said the businesses delivered “strong operating results and excellent cash conversion.” Operating cash flow hit $2.155 billion, a swing from negative territory a year ago.

Lockheed told a different story. EPS of $6.44 missed consensus of $6.70, revenue rose just 0.3%, and free cash flow went negative $291 million. A $125 million unfavorable F-16 adjustment plus hits on C-130, CH-53K, and Seahawk compressed segment margins to 10.1% from 11.6%. That is the second painful quarter in a year, following $1.6 billion in charges in Q2 2025.

A Deep Marine Moat Versus a Concentrated Fighter Bet

General Dynamics compounds a two-submarines-per-year cadence with commercial jets and defense IT, giving it a diversified earnings base tied to both long-term government and commercial demand. Total estimated contract value climbed to $188.44 billion, and consolidated book-to-bill ran 2-to-1.

Lockheed’s backlog is bigger at $194 billion, but heavier in fixed-price aeronautics work where losses keep resurfacing. New framework agreements for Patriot, THAAD, and PrSM should eventually lift production rates 3-4x, according to Jim Taiclet, yet near-term earnings look wobbly.

Lens GD LMT
Core Bet Nuclear submarines + Gulfstream F-35 and missile framework deals
Q1 Free Cash Flow $1.952B -$291M
Forward P/E 21x 17x

The Next Test Is Execution

Watch whether Lockheed closes F-16 issues and stabilizes CH-53K without another reach-forward loss. Guidance calling for $6.5B to $6.8B in 2026 free cash flow assumes a sharp back-half recovery. For General Dynamics, signals are Gulfstream deliveries, further Virginia-class submarine funding tied to the FY2027 shipbuilding budget of $65.8 billion, and whether Technologies margins can stop drifting from 9.5%.

Why I Lean Toward General Dynamics on This Earnings Report

General Dynamics looks like the cleaner defense holding. Cash conversion at 192% of net earnings, four straight EPS beats, and a submarine franchise with visible funding give it real downside protection. Lockheed’s $194B backlog and geopolitical tailwinds could reward patient turnaround investors, and Jefferies’ $400 target on GD shows the Street is warming up. For a defensive compounder profile, General Dynamics screens cleaner. For investors focused on fixed-price program noise in a rerating story, Lockheed still has a case.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

MRNA Vol: 8,108,909
BSX Vol: 11,898,562
UHS Vol: 494,241
HCA Vol: 780,043
ISRG Vol: 1,241,215

Top Losing Stocks

TER Vol: 2,080,083
KLA
KLAC Vol: 8,594,184
GLW Vol: 11,982,948
STX Vol: 2,568,409
AMAT Vol: 6,602,622